title: Is There Evidence of Any Safety Differences Among DPP-4 Inhibitors in the Treatment of People with Type 2 Diabetes Mellitus and Reduced GFR Due to Chronic Kidney Disease?
authors.affiliation: University Hospital Llandough, Cardiff, UK, marcevans4@sky.com.
authors.forename: Marc
authors.initials: M
authors.lastname: Evans
authors.forename: Sylvie
authors.initials: S
authors.lastname: Dejager
authors.forename: Anja
authors.initials: A
authors.lastname: Schweizer
authors.forename: James E
authors.initials: JE
authors.lastname: Foley